Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

Nischarin Inhibitors

Nischarin inhibitors as a chemical class are defined by their ability to interact with and modulate signaling pathways that involve the Nischarin protein. These compounds typically target key signaling molecules or enzymes such as phosphoinositide 3-kinases (PI3K), mitogen-activated protein kinases (MAPKs), and mammalian target of rapamycin (mTOR), which are all upstream or downstream of where Nischarin functions. The inhibition of these signaling nodes can result in the alteration of cellular processes such as migration, proliferation, and adhesion that Nischarin is known to influence. The chemical structures of these compounds vary widely, from the macrolide structure of rapamycin to the small molecular inhibitors like LY294002, each designed to fit into the active sites of their target enzymes or signaling molecules. Given the role of Nischarin in various signaling pathways, the indirect inhibitors mentioned play a role in modulating the biological processes associated with Nischarin. These inhibitors are typically used in a research context to understand the complex signaling networks within the cell. The pathways targeted by these inhibitors, such as the PI3K/Akt pathway, MAPK pathway, and the mTOR signaling pathway, are integral to cell survival, proliferation, and differentiation. Inhibition of these pathways can lead to altered cell behavior which indirectly suggests the role Nischarin might play within these pathways. These chemicals are tools that provide insight into cellular signaling and are valuable in dissecting the intricate molecular interactions in which proteins like Nischarin participate.

SEE ALSO...

Items 11 to 14 of 14 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

Similar to Gefitinib, it inhibits EGFR and can alter downstream effects impacting Nischarin-related signaling.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

A dual tyrosine kinase inhibitor targeting HER2 and EGFR, which can affect pathways involving Nischarin.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

A multikinase inhibitor that can influence various pathways, including those associated with Nischarin.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Another multikinase inhibitor that targets receptor tyrosine kinases, potentially affecting Nischarin-related signaling.